Pacific Biosciences of California, Inc. Income (Loss) from Continuing Operations, Per Diluted Share
Pacific Biosciences of California, Inc. (PACB) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$0.02 per share for the 3-month period ending 2015-12-31, per its 10-K filed 2017-03-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2017-03-06
- Pacific Biosciences of California, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2015-12-31 was -$0.02.
- Pacific Biosciences of California, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2015-09-30 was $0.02.
- Pacific Biosciences of California, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2015-06-30 was -$0.16.
- Pacific Biosciences of California, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2015-03-31 was -$0.27.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month |
|---|---|
| 2015-12-31 | -$0.02 10-K · filed 2017-03-06 |
| 2015-09-30 | $0.02 10-K · filed 2017-03-06 |
| 2015-06-30 | -$0.16 10-K · filed 2017-03-06 |
| 2015-03-31 | -$0.27 10-K · filed 2017-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |